BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8605349)

  • 1. Interleukin-15 promotes the growth of leukemic cells of patients with B-cell chronic lymphoproliferative disorders.
    Trentin L; Cerutti A; Zambello R; Sancretta R; Tassinari C; Facco M; Adami F; Rodeghiero F; Agostini C; Semenzato G
    Blood; 1996 Apr; 87(8):3327-35. PubMed ID: 8605349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional role of the p75 interleukin 2 receptor chain on leukemic hairy cells.
    Trentin L; Zambello R; Benati C; Cassatella M; Agostini C; Bulian P; Adami F; Carra G; Pizzolo G; Semenzato G
    Cancer Res; 1992 Oct; 52(19):5223-8. PubMed ID: 1394125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia.
    Trentin L; Zambello R; Agostini C; Enthammer C; Cerutti A; Adami F; Zamboni S; Semenzato G
    Blood; 1994 Dec; 84(12):4249-56. PubMed ID: 7994039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
    Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
    Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
    Carlsson M; Tötterman TH; Rosén A; Nilsson K
    Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
    Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
    Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic analysis of hairy cell leukemia: "variant" cases express the interleukin-2 receptor beta chain, but not the alpha chain (CD25).
    de Totero D; Tazzari PL; Lauria F; Raspadori D; di Celle PF; Carbone A; Gobbi M; Foa R
    Blood; 1993 Jul; 82(2):528-35. PubMed ID: 8329708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.
    Carson WE; Giri JG; Lindemann MJ; Linett ML; Ahdieh M; Paxton R; Anderson D; Eisenmann J; Grabstein K; Caligiuri MA
    J Exp Med; 1994 Oct; 180(4):1395-403. PubMed ID: 7523571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectors.
    Foa R; Fierro MT; Raspadori D; Bonferroni M; Cardona S; Guarini A; Tos AG; di Celle PF; Cesano A; Matera L
    Blood; 1990 Oct; 76(7):1349-54. PubMed ID: 2207312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin of the soluble interleukin-2 receptor in the serum of patients with hairy cell leukemia.
    Semenzato G; Trentin L; Zambello R; Agostini C; Bulian P; Siviero F; Ambrosetti A; Vinante F; Prior M; Chilosi M
    Leukemia; 1988 Dec; 2(12):788-92. PubMed ID: 3264362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
    Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
    Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of interleukin 2 receptors on B-cell chronic lymphocytic leukemia cells.
    Tsilivakos V; Tsapis A; Kakolyris S; Iliakis P; Perraki M; Georgoulias V
    Leukemia; 1994 Sep; 8(9):1571-8. PubMed ID: 8090033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-2 receptor complex: expression and function on normal and leukemic B cells.
    de Totero D; Francia di Celle P; Cignetti A; Foa R
    Leukemia; 1995 Sep; 9(9):1425-31. PubMed ID: 7658707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
    Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
    Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
    Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
    Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
    Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
    Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: a possible regulatory role of TNF in the progression of the disease.
    Foa R; Massaia M; Cardona S; Tos AG; Bianchi A; Attisano C; Guarini A; di Celle PF; Fierro MT
    Blood; 1990 Jul; 76(2):393-400. PubMed ID: 2114936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of signal transduction in B chronic lymphocytic leukemia cells.
    Drexler HG; Brenner MK; Coustan-Smith E; Gignac SM; Hoffbrand AV
    Blood; 1988 May; 71(5):1461-9. PubMed ID: 3129049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AML blasts variably express interleukin 2 receptor alpha, beta or gamma chains without measurable effects on proliferation, cytokine message expression or surface expression of adhesion molecules upon stimulation with interleukin 2.
    Weidmann E; Brieger J; Bergmann L; Hoelzer D; Mitrou PS
    Leuk Res; 1995 Jul; 19(7):469-76. PubMed ID: 7637393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.